HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...

The Super Bowl is always packed with attention-grabbing ads, but Novartis’s cleavage-packed commercial created particularly ...

Eating well can help support your immune system and maintain strength and energy if you have HER2-negative breast cancer, ...

National Cancer Prevention Month encourages communities to educate themselves on what cancer is. Cancer can grow on any organ ...

An Arkansas mom of three is sharing her story of overcoming breast cancer, and how an unexpected genetic twist led to some ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Chemists at Emory University have invented a reaction to streamline the total synthesis of a compound, phaeocaulisin A, ...

Oncologist Dr. Sarah Cate told Newsweek: "Many women simply don't make time for themselves, since they are working and often ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

Patients with ERBB2-positive breast cancer and CNS-only metastasis are at a high risk for CNS-related death but have longer overall survival than those with concomitant extracranial metastases.